Genzyme: Icahn's interest does not signal merger

Genzyme Corp. insists that investor Carl Icahn's interest in the company will not prompt a takeover. "To integrate us to into a very large entity is not that attractive. [The company] is much stronger as it is right now -- as a stand-alone rather than as part of a company 10 times our size," chief executive Henri Termeer said in an interview.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Actuary
Meridian Health Plan
Detroit, MI
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX